Drug
Treprostinil Diolamine
Treprostinil Diolamine: highest development phase Phase 3, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Treprostinil Diolamine NCT01560624 | Phase 3 | Pulmonary Arterial Hypertension |
Latest
No recent events.
Follow Treprostinil Diolamine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.